Light-Activated ointment shows promise for rare skin cancer
Disease control
Completed
This study tested a synthetic ointment called hypericin (HyBryte) combined with visible light to treat mycosis fungoides, a rare type of skin lymphoma. Ten adults with early-stage disease applied the ointment and received light treatments every 6 weeks for up to 54 weeks. The goa…
Phase: PHASE2 • Sponsor: Ellen Kim, MD • Aim: Disease control
Last updated May 13, 2026 15:59 UTC